P2X3 receptor in injured human sensory neurons

NeuroReport

Volumn 11, Issue 5, 2000, Pages 993-996

  Yiangou, Y ^c   Facer, P ^c   Birch, R ^a   Sangameswaran, L ^b   Eglen, R ^b   Anand, P ^c  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b ROCHE BIOSCIENCE   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Adenosine 5' triphosphate; Immunohistochemistry; P2X3; Sensory neurones; Western blotting

Indexed keywords

PURINE P2X RECEPTOR; PURINE P2 RECEPTOR; PURINE P2X3 RECEPTOR;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYENTERIC PLEXUS; NERVE FIBER TRANSECTION; NERVE INJURY; NOCICEPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSORY NERVE; AUTONOMIC GANGLION; INJURY; INTESTINE INNERVATION; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; SENSORY NERVE CELL; SPINAL GANGLION; WESTERN BLOTTING;

ADULT; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; ENTERIC NERVOUS SYSTEM; GANGLIA, AUTONOMIC; GANGLIA, SPINAL; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NEURONS, AFFERENT; RECEPTORS, PURINERGIC P2;

EID: 0034615753     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200004070-00019     Document Type: Article

References (19)

1. 1. Evans RJ, Derkach V and Surprenant A. Nature 357, 503-505 (1992).
2. 2. Edwards FA, Gibb AJ and Colquhoun D. Nature 359, 144-147 (1992).
3. 3. Fredholm BP, Abbracchio MP, Burnstock G et al. Pharmacol Rev 46, 143-156 (1994).
4. 4. North RA and Barnard EA. Curr Opin Neurobiol 7, 346-357 (1997).
5. 5. Collo G, North RA, Kawashima E et al. J Neurosci 16, 2495-2507 (1996).
6. 6. Seguela P, Haghighi A, Soghomonian JJ et al. J Neurosci 16, 448-455 (1996).
7. 7. Chen CC, Akopian AN, Sivilotti L et al. Nature 377, 428-431 (1995).
8. 8. Cook SP, Vulchananova L, Hargreaves KM et al. Nature 387, 505-508 (1997).
9. 9. Lewis C, Neidhart S, Holy C et al. Nature 377, 432-435 (1995).
10. 10. Valera S, Talabot F, Evans RJ et al. Receptor Channels 3, 283-289 (1995).
11. 11. Garcia-Guzman M, Soto F, Gomez-Hernandez JM et al. Mol Pharmacol 51, 109-118 (1997).
12. 12. Garcia-Guzman M, Stuhmer W and Soto F. Mol Brain Res 47, 59-66 (1997).
13. 13. Bradbury EJ, Burnstock G and McMahon SB. Mol Cell Neurosci 12, 256-268 (1998).
14. 14. Shu S, Ju G and Fan L. Neurosci Lett 85, 169-171 (1988).
15. 15. Novakovic SD, Kassotakis C, Oglesby IB et al. Pain 80, 273-282 (1999).
16. 16. Vulchanova L, Riedl MS, Shuster SJ et al. Eur J Neurosci 10, 3470-3478, (1998).
17. 17. Chen Y, Shu Y and Zhao Z. Neuroreport 10, 2779-2782 (1999).
18. 18. Namasivayam S, Eardley I and Morrison JFB. BJU Int 84, 854-860 (1999).
19. 19. McCleskey EW and Gold MS. Annu Rev Physiol 61, 835-856 (1999).